None listed
Conditions
Brief summary
To determine whether use of the Funhaler,as a spacer for administation of asthma preventive treatment, has an influence on adherence to medication, drug delivery, and eventually if its use can improve asthma control.
Interventions
Use of the Funhaler instead of a conventional spacer. The Funhaler is commercialy available small volume spacer with a spinning disk and whistle on the exhalatory arm. The study group will be asked to use the Funhaler instead of their conventional spacer for administering their daily inhaled steroids (they have to be on regular inhaled steroids as part of the inclusion criteria). Each participant will be followed up for one year. If any study participant should be weaned off their inhaled st
Use of the Funhaler instead of a conventional spacer. The Funhaler is commercialy available small volume spacer with a spinning disk and whistle on the exhalatory arm. The study group will be asked to use the Funhaler instead of their conventional spacer for administering their daily inhaled steroids (they have to be on regular inhaled steroids as part of the inclusion criteria). Each participant will be followed up for one year. If any study participant should be weaned off their inhaled steroids during the course of the study( by the study doctor or by their GP), because their asthma is well controlled, they will still be followed up.
Sponsors
National Institute of Health
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
2 Years to 6 Years
Healthy volunteers
No
Inclusion criteria
Doctor dianosed asthma Age 2-6 years On inhaled steroid treatment
Exclusion criteria
On oral steroids past 3 months Chronic lung disease other than asthma Allergy to Flixotide Known immunodeficiency
Outcome results
None listed